[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Is Agilent Technologies Stock Outperforming the Nasdaq?

Agilent Technologies has outperformed the Nasdaq recently, and analysts remain highly optimistic about the stock’s prospects.

A : 128.95 (-2.03%)
$NASX : 25,277.65 (+0.43%)
TMO : 471.14 (-2.26%)
2 of Wall Street’s Favorite Stocks with Exciting Potential and 1 Facing Challenges

2 of Wall Street’s Favorite Stocks with Exciting Potential and 1 Facing Challenges

DY : 456.04 (+2.28%)
TMO : 471.14 (-2.26%)
CR : 200.29 (+2.37%)
Is Thermo Fisher Scientific Stock Underperforming the S&P 500?

Despite Thermo Fisher Scientific's underperformance relative to the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

$SPX : 7,286.20 (+0.26%)
TMO : 471.14 (-2.26%)
DHR : 180.46 (-1.73%)
3 Cash-Producing Stocks We Steer Clear Of

3 Cash-Producing Stocks We Steer Clear Of

TMO : 471.14 (-2.26%)
CRMT : 2.79 (+17.72%)
AGYS : 91.57 (+0.46%)
Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies

New mass spectrometry platforms, combined with AI-driven analytics and scalable proteomics solutions, help scientists turn complex biology into actionable insights across research and drug development

TMO : 471.14 (-2.26%)
Thermo Fisher Scientific Announces Quarterly Dividend

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on July...

TMO : 471.14 (-2.26%)
Thermo Fisher Scientific Highlights Industry Leadership, Growth Outlook and Long-Term Value Creation at 2026 Investor Day

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, hosted its Investor Day today. Chairman and Chief Executive Officer Marc N. Casper and members of the senior leadership team...

TMO : 471.14 (-2.26%)
Do Wall Street Analysts Like Thermo Fisher Scientific Stock?

While Thermo Fisher Scientific has considerably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects.

XLV : 154.07 (+0.80%)
$SPX : 7,286.20 (+0.26%)
TMO : 471.14 (-2.26%)
1 S&P 500 Stock with Promising Prospects and 2 We Ignore

1 S&P 500 Stock with Promising Prospects and 2 We Ignore

MS : 208.34 (+0.81%)
KMI : 31.85 (+0.03%)
TMO : 471.14 (-2.26%)
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

COLL : 34.94 (+0.40%)
TMO : 471.14 (-2.26%)
XRAY : 9.90 (-1.39%)
HALO : 70.64 (+0.20%)

Barchart Exclusives

CubeSmart Stock Is Primed for a Breakout – and It Pays You to Wait with a 5.1% Dividend Yield
CubeSmart (CUBE) shares have carved out a highly visible technical floor around the $38 to $41 range, absorbing sector-wide real estate headwinds. That sector is showing signs of a long-awaited breakout from a consolidation phase. The stock currently carries an 100% “Buy” overall technical opinion from Barchart, indicating strong medium-... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.